Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI

Clinical trial NCT07231939 · RECRUITING

Trial details

NCT number: NCT07231939
Sponsor: Collegium Medicum w Bydgoszczy
Status: RECRUITING
Study type: OBSERVATIONAL

Coronary Artery Disease Acute Kidney Injury Contrast-Induced Acute Kidney Injury Percutaneous Coronary Intervention

Start date: 2025-11-01
Primary completion: 2025-12-31
Enrollment: 4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.